Werewolf Therapeutics (HOWL) Financial Statements
Price: $0.919
Market Cap: $41.20M
Avg Volume: 261.37K
Market Cap: $41.20M
Avg Volume: 261.37K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Werewolf Therapeutics.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Revenue | $1.89M | $19.94M | $16.40M | $- | $- | $- |
| Cost of Revenue | $- | $38.91M | $2.51M | $735.00K | $777.00K | $463.00K |
| Gross Profit | $1.89M | $-18.96M | $13.89M | $-735.00K | $-777.00K | $-463.00K |
| Gross Profit Ratio | 100.00% | -95.09% | 84.70% | - | - | - |
| Research and Development Expenses | $56.43M | $41.78M | $53.76M | $35.27M | $16.64M | $6.34M |
| General and Administrative Expenses | $19.05M | $18.67M | $18.70M | $14.82M | $5.76M | $3.60M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $19.05M | $18.67M | $18.70M | $14.82M | $5.76M | $3.60M |
| Other Expenses | $- | $- | $2.25M | $104.00K | $7.26M | $430.00K |
| Operating Expenses | $75.48M | $60.45M | $72.46M | $50.09M | $22.40M | $9.94M |
| Cost and Expenses | $75.48M | $60.45M | $72.46M | $50.09M | $22.40M | $9.94M |
| Interest Income | $6.67M | $7.42M | $1.91M | $104.00K | $101.00K | $372.00K |
| Interest Expense | $4.66M | $3.14M | $- | $- | $- | $372.00K |
| Depreciation and Amortization | $1.81M | $1.76M | $2.51M | $735.00K | $777.00K | $463.00K |
| EBITDA | $-64.05M | $-32.47M | $-51.30M | $-49.25M | $-14.26M | $-9.41M |
| EBITDA Ratio | -3397.61% | -162.79% | -312.79% | - | - | - |
| Operating Income | $-73.59M | $-40.50M | $-56.06M | $-50.09M | $-22.40M | $-9.94M |
| Operating Income Ratio | -3904.19% | -203.09% | -341.78% | - | - | - |
| Total Other Income Expenses Net | $3.08M | $3.13M | $2.25M | $104.00K | $7.36M | $-312.00K |
| Income Before Tax | $-70.52M | $-37.37M | $-53.81M | $-49.98M | $-15.04M | $-10.25M |
| Income Before Tax Ratio | -3740.85% | -187.37% | -328.09% | - | - | - |
| Income Tax Expense | $- | $- | $-2.25M | $-216.00K | $-101.00K | $742.00K |
| Net Income | $-70.52M | $-37.37M | $-51.56M | $-49.77M | $-14.94M | $-10.99M |
| Net Income Ratio | -3740.85% | -187.37% | -314.40% | - | - | - |
| EPS | $-1.63 | $-1.05 | $-1.79 | $-1.82 | $-0.52 | $-0.38 |
| EPS Diluted | $-1.61 | $-1.05 | $-1.79 | $-1.82 | $-0.52 | $-0.38 |
| Weighted Average Shares Outstanding | 43.33M | 35.65M | 28.86M | 27.31M | 28.66M | 28.66M |
| Weighted Average Shares Outstanding Diluted | 43.86M | 35.65M | 28.86M | 27.31M | 28.66M | 28.66M |
| SEC Filing | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $112.22M | $134.34M | $129.31M | $157.53M | $92.57M | $17.90M |
| Short Term Investments | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $112.22M | $134.34M | $129.31M | $157.53M | $92.57M | $17.90M |
| Net Receivables | $- | $1.35M | $6.93M | $- | $- | $- |
| Inventory | $- | $- | $2 | $- | $- | $- |
| Other Current Assets | $851.00K | $2.68M | $3.96M | $7.07M | $688.00K | $167.00K |
| Total Current Assets | $113.07M | $138.37M | $140.20M | $161.07M | $92.91M | $18.06M |
| Property Plant Equipment Net | $12.32M | $14.85M | $17.45M | $16.32M | $3.12M | $3.41M |
| Goodwill | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $1.21M | $1.21M | $207.00K | $208.00K |
| Tax Assets | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $1.54M | $21.62M | $1.38M | $649.00K | $155.00K | $- |
| Total Non-Current Assets | $13.86M | $36.46M | $20.05M | $18.18M | $3.48M | $3.62M |
| Other Assets | $- | $- | $- | $- | $- | $- |
| Total Assets | $126.93M | $174.83M | $160.25M | $179.25M | $96.40M | $21.68M |
| Account Payables | $3.04M | $1.34M | $1.22M | $2.04M | $1.02M | $633.00K |
| Short Term Debt | $1.56M | $8.28M | $4.17M | $2.14M | $677.00K | $595.00K |
| Tax Payables | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $907.00K | $6.53M | $- | $- | $- |
| Other Current Liabilities | $10.59M | $8.86M | $12.07M | $7.69M | $3.59M | $816.00K |
| Total Current Liabilities | $15.18M | $19.38M | $23.99M | $11.87M | $5.28M | $2.04M |
| Long Term Debt | $9.44M | $43.65M | $25.20M | $29.18M | $1.86M | $2.54M |
| Deferred Revenue Non-Current | $- | $433.00K | $1.13M | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $28.92M | $- | $-12.41M | $-14.59M | $141.11M | $41.40M |
| Total Non-Current Liabilities | $38.36M | $44.08M | $13.92M | $14.59M | $142.98M | $43.94M |
| Other Liabilities | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $53.54M | $63.46M | $37.91M | $26.46M | $148.26M | $45.98M |
| Preferred Stock | $- | $- | $- | $179.25M | $141.08M | $34.07M |
| Common Stock | $5.00K | $4.00K | $3.00K | $2.00K | $2.00K | $2.00K |
| Retained Earnings | $-414.59M | $-344.07M | $-306.70M | $-252.90M | $-51.87M | $-24.41M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $-179.25M | $-141.08M | $-34.07M |
| Other Total Stockholders Equity | $487.97M | $455.44M | $429.04M | $405.68M | $2.00K | $68.15M |
| Total Stockholders Equity | $73.39M | $111.37M | $122.34M | $152.79M | $-51.86M | $-24.30M |
| Total Equity | $73.39M | $111.37M | $122.34M | $152.79M | $-51.86M | $-24.30M |
| Total Liabilities and Stockholders Equity | $126.93M | $174.83M | $160.25M | $179.25M | $96.40M | $21.68M |
| Minority Interest | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $126.93M | $174.83M | $160.25M | $179.25M | $96.40M | $21.68M |
| Total Investments | $- | $21.02M | $1.21M | $1.21M | $207.00K | $208.00K |
| Total Debt | $10.99M | $51.92M | $14.68M | $15.66M | $2.54M | $3.14M |
| Net Debt | $-101.22M | $-82.42M | $-114.63M | $-141.87M | $-90.03M | $-14.76M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Net Income | $-70.52M | $-37.37M | $-53.81M | $-49.98M | $-15.04M | $-10.25M |
| Depreciation and Amortization | $1.81M | $1.76M | $1.10M | $216.00K | $150.00K | $25.00K |
| Deferred Income Tax | $- | $- | $- | $- | $-7.30M | $-117.00K |
| Stock Based Compensation | $8.83M | $8.01M | $7.40M | $4.09M | $632.00K | $559.00K |
| Change in Working Capital | $2.53M | $-5.89M | $2.54M | $2.28M | $2.31M | $-711.00K |
| Accounts Receivables | $- | $5.58M | $-6.93M | $- | $- | $- |
| Inventory | $- | $- | $6.93M | $- | $- | $- |
| Accounts Payables | $3.46M | $-4.33M | $-883.00K | $1.01M | $388.00K | $116.00K |
| Other Working Capital | $-929.00K | $-7.14M | $3.42M | $1.27M | $1.92M | $-827.00K |
| Other Non Cash Items | $1.16M | $878.00K | $2.17M | $519.00K | $627.00K | $950.00K |
| Net Cash Provided by Operating Activities | $-56.19M | $-32.61M | $-40.60M | $-42.88M | $-18.62M | $-9.54M |
| Investments in Property Plant and Equipment | $-254.00K | $-769.00K | $-3.61M | $-498.00K | $-560.00K | $-266.00K |
| Acquisitions Net | $- | $- | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $- | $- | $- | $- | $- | $- |
| Net Cash Used for Investing Activities | $-254.00K | $-769.00K | $-3.61M | $-498.00K | $-560.00K | $-266.00K |
| Debt Repayment | $-10.00M | $40.00M | $- | $- | $- | $- |
| Common Stock Issued | $23.58M | $18.33M | $15.74M | $111.60M | $94.01M | $2.00K |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-496.00K | $100.00K | $166.00K | $-2.17M | $94.02M | $21.91M |
| Net Cash Used Provided by Financing Activities | $13.08M | $58.43M | $15.91M | $109.43M | $93.86M | $21.91M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-43.36M | $25.05M | $-28.30M | $66.05M | $74.67M | $12.10M |
| Cash at End of Period | $112.22M | $155.58M | $130.53M | $158.83M | $92.78M | $18.10M |
| Cash at Beginning of Period | $155.58M | $130.53M | $158.83M | $92.78M | $18.10M | $6.00M |
| Operating Cash Flow | $-56.19M | $-32.61M | $-40.60M | $-42.88M | $-18.62M | $-9.54M |
| Capital Expenditure | $-254.00K | $-769.00K | $-3.61M | $-498.00K | $-560.00K | $-266.00K |
| Free Cash Flow | $-56.44M | $-33.38M | $-44.21M | $-43.37M | $-19.18M | $-9.81M |